Hydrogenology
Source-linked study record

A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss

Okada M, Ogawa H, Takagi T, Nishihara E, Yoshida T, Hyodo J, Shinomori Y, Honda N, Fujiwara T, Teraoka M, Yamada H, Hirano SI, Hato N. · Frontiers in neuroscience. 2022;16:1024634.

HumanInhaled H₂Published 2022Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Human participants studied for other neurological conditions. See eligibility criteria in the linked full text.

Intervention and dose

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 6 days, 1 month, 3%. · H₂-related quantities reported in the intervention passages: 6 days, 1 month, 3%. Values are not combined across different experimental arms.

Duration

6 days

Reported result

Article-reported result excerpt (24 words maximum): “Furthermore, the ratio of good hearing prognosis (complete and partial recoveries) 3 months after treatment was 64.5% ( n = 20) and 58.8% (…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Human evidence; design, sample size and comparator limit interpretation. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Randomized controlled study

Research topic

Other neurological conditions

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Human participants studied for other neurological conditions. See eligibility criteria in the linked full text.

Sample

Human study; group or assay counts reported in the full text include n=3, n=4, n=1, n=6, n=31, n=34.

Duration

6 days

Intervention

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 6 days, 1 month, 3%.

Hydrogen form

Inhaled molecular H₂; not classified as Brown’s gas without an H₂/O₂ composition.

Dose or H₂ specification

H₂-related quantities reported in the intervention passages: 6 days, 1 month, 3%. Values are not combined across different experimental arms.

H₂ flow

Not reported in the full article — an absolute H₂ flow in mL/min could not be verified.

O₂ delivered with H₂

O₂ concentration and absolute O₂ flow were not both reported in the full article; no value is inferred.

Comparator

Placebo or matched control reported in the full article.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

clinical symptoms or functional scores, oxidative-stress and antioxidant markers, apoptosis or cell injury, cardiovascular measures, respiratory measures

Reported result

Article-reported result excerpt (24 words maximum): “Furthermore, the ratio of good hearing prognosis (complete and partial recoveries) 3 months after treatment was 64.5% ( n = 20) and 58.8% (…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Human evidence; design, sample size and comparator limit interpretation. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Applies directly to

Applies only to the population and protocol reported in this other neurological conditions article.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 36507329 · DOI: 10.3389/fnins.2022.1024634

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed/PMC full article; source identity, intervention data and declarations re-audited 25 August 2026.

Last reviewed

29 September 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.